Speech-Language Pathologists in Lovell, WY Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Mrs. Tashie Renae Lundberg Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 435 E 5th St, Lovell, WY 82431 Phone: 307-548-6722 Fax: 307-548-6700 |
Andrea Violet Whitaker, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 435 E 5th St, Lovell, WY 82431 Phone: 307-548-6722 Fax: 307-548-6700 |
Mrs. Heather Kay Moretti Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1115 Lane 12, Lovell, WY 82431 Phone: 307-548-5200 Fax: 307-548-5665 |
Mrs. Hannah May, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 435 E 5th St, Lovell, WY 82431 Phone: 307-548-6722 |
 Dirk Schroeder Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1115 Lane 12, Lovell, WY 82431 Phone: 307-548-5200 |
News Archive
New method could lead to better understanding of complex interactions between human gut microbes
The gut microbiome - the world of microbes that inhabit the human intestinal tract - has captured the interest of scientists and clinicians for its critical role in health.
Genesis Biopharma closes private offerings to purchase 845,000 shares of common stock
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer therapies, today announced that it closed private offerings in December and October 2010 pursuant to which it entered into definitive agreements with accredited investors to purchase a total of 845,000 shares of the Genesis Biopharma common stock for a purchase price of $1.00 per share.
UCI awarded $1 million to participate in multi-site health study of contaminated drinking water
The University of California, Irvine was awarded $1 million by the U.S. Centers for Disease Control and Prevention and Agency for Toxic Substances and Disease Registry to participate in the first year of a major multi-site health study to investigate the relationship between drinking water contaminated with per- and polyfluoroalkyl substances and health outcomes.
Spectrum Pharmaceuticals receives $977,900 grant under QTDP program
Spectrum Pharmaceuticals, Inc. a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has been awarded grants totaling $977,900 under the Qualifying Therapeutic Discovery Project (QTDP) Program administered under section 48D of the Internal Revenue Code.
Genevac's Rocket evaporators set standard for rapid, sample-safe operation
Designed for laboratories tasked with handling larger sample volumes - Rocket evaporators from Genevac set the standard for productive, sample-safe operation.
› Verified 9 days ago
Speech-Language Pathologists
Chiropractors
Optometrists
Physical Therapists